KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Operating Expenses: 2018-2024

Historic Other Operating Expenses for Ionis Pharmaceuticals (IONS) over the last 7 years, with Dec 2024 value amounting to -$12,000.

  • Ionis Pharmaceuticals' Other Operating Expenses rose 118.30% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 12.77%. This contributed to the annual value of -$12,000 for FY2024, which is 92.55% up from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Other Operating Expenses of -$12,000 as of FY2024, which was up 92.55% from -$161,000 recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' Other Operating Expenses registered a high of $149.6 million during FY2022, and its lowest value of -$161,000 during FY2023.
  • For the 3-year period, Ionis Pharmaceuticals' Other Operating Expenses averaged around $49.8 million, with its median value being -$12,000 (2024).
  • In the last 5 years, Ionis Pharmaceuticals' Other Operating Expenses skyrocketed by 1,279.86% in 2022 and then tumbled by 100.11% in 2023.
  • Yearly analysis of 5 years shows Ionis Pharmaceuticals' Other Operating Expenses stood at $11.9 million in 2020, then decreased by 9.25% to $10.8 million in 2021, then spiked by 1,279.86% to $149.6 million in 2022, then crashed by 100.11% to -$161,000 in 2023, then spiked by 92.55% to -$12,000 in 2024.